Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Jul;147(1):207–216.

De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.

A Matolcsy 1, A Chadburn 1, D M Knowles 1
PMCID: PMC1869880  PMID: 7541611

Abstract

Diffuse large B cell lymphomas (DLBLs) represent a heterogeneous collection of aggressive non-Hodgkin's lymphomas that can arise either de novo or as a result of transformation from chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphomas, or lymphomas of mucosa-associated lymphoid tissue. A small percentage of DLBLs express the CD5 antigen. The majority of these cases have evolved from a pre-existing low grade non-Hodgkin's lymphoma (Richter's syndrome). However, we identified and characterized nine CD5-positive DLBLs in which the patients did not have a previous history or concomitant evidence of chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma, or mucosa-associated lymphoid tissue-associated non-Hodgkin's lymphoma, suggesting that they arose de novo. All nine cases expressed CD20 and monotypic immunoglobulin, all eight cases examined expressed CD19, CD22 and CD43, eight of the nine cases expressed HLA-DR, and two of eight cases expressed CD11c. None of the cases expressed CD3, CD10, CD11b, CD21, CD23 or CD30. CD5 expression by these cells was found to be identical to that of CD5-positive B cell chronic lymphocytic leukemia by quantitative polymerase chain reaction analysis of CD5 mRNA. These nine de novo CD5-positive DLBLs exhibited clonal immunoglobulin heavy and light chain gene rearrangements but lacked integration of the Epstein-Barr virus genome and structural alterations of the bcl-1, bcl-2, c-myc, H-ras, K-ras, and N-ras proto-oncogenes and the p53 tumor suppressor gene. However, bcl-6 proto-oncogene rearrangement, which is involved in chromosome band 3q27 aberrations, was found in four cases (44.4%). This is comparable with the frequency of bcl-6 gene rearrangement in CD5-negative DLBL. In contrast, bcl-6 gene rearrangement was absent in six cases of DLBL associated with Richter's syndrome. These findings suggest that de novo CD5-positive DLBLs are genotypically similar to CD5-negative DLBLs and may be pathogenetically distinct from the DLBLs associated with Richter's syndrome.

Full text

PDF
207

Images in this article

211Figure 1
on p.211
212Figure 2
on p.212
213Figure 3
on p.213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bateman A. C., Wright D. H. Epitheliotropism in high-grade lymphomas of mucosa-associated lymphoid tissue. Histopathology. 1993 Nov;23(5):409–415. doi: 10.1111/j.1365-2559.1993.tb00488.x. [DOI] [PubMed] [Google Scholar]
  2. Burastero S. E., Casali P. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce. Contrib Microbiol Immunol. 1989;11:231–262. [PubMed] [Google Scholar]
  3. Burns B. F., Warnke R. A., Doggett R. S., Rouse R. V. Expression of a T-cell antigen (Leu-1) by B-cell lymphomas. Am J Pathol. 1983 Nov;113(2):165–171. [PMC free article] [PubMed] [Google Scholar]
  4. Casali P., Notkins A. L. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol. 1989;7:513–535. doi: 10.1146/annurev.iy.07.040189.002501. [DOI] [PubMed] [Google Scholar]
  5. Chan J. K., Ng C. S., Isaacson P. G. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol. 1990 May;136(5):1153–1164. [PMC free article] [PubMed] [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  7. Cleary M. L., Galili N., Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med. 1986 Jul 1;164(1):315–320. doi: 10.1084/jem.164.1.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cleary M. L., Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7439–7443. doi: 10.1073/pnas.82.21.7439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  10. Dorfman D. M., Pinkus G. S. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol. 1994 Apr;7(3):326–331. [PubMed] [Google Scholar]
  11. Farrugia M. M., Duan L. J., Reis M. D., Ngan B. Y., Berinstein N. L. Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translocations of the c-MYC and BCL-2 proto-oncogenes. Blood. 1994 Jan 1;83(1):191–198. [PubMed] [Google Scholar]
  12. Foon K. A., Thiruvengadam R., Saven A., Bernstein Z. P., Gale R. P. Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med. 1993 Jul 1;119(1):63–73. doi: 10.7326/0003-4819-119-1-199307010-00011. [DOI] [PubMed] [Google Scholar]
  13. Gaidano G., Ballerini P., Gong J. Z., Inghirami G., Neri A., Newcomb E. W., Magrath I. T., Knowles D. M., Dalla-Favera R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5413–5417. doi: 10.1073/pnas.88.12.5413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  15. Hayakawa K., Hardy R. R., Herzenberg L. A., Herzenberg L. A. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med. 1985 Jun 1;161(6):1554–1568. doi: 10.1084/jem.161.6.1554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hubbard S. M., Chabner B. A., DeVita V. T., Jr, Simon R., Berard C. W., Jones R. B., Garvin A. J., Canellos G. P., Osborne C. K., Young R. C. Histologic progression in non-Hodgkin's lymphoma. Blood. 1982 Feb;59(2):258–264. [PubMed] [Google Scholar]
  17. Inghirami G., Zhu B. Y., Chess L., Knowles D. M. Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood. Am J Pathol. 1990 Feb;136(2):357–367. [PMC free article] [PubMed] [Google Scholar]
  18. Jacobson J. O., Wilkes B. M., Kwaiatkowski D. J., Medeiros L. J., Aisenberg A. C., Harris N. L. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer. 1993 Jul 1;72(1):231–236. doi: 10.1002/1097-0142(19930701)72:1<231::aid-cncr2820720141>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  19. Jones N. H., Clabby M. L., Dialynas D. P., Huang H. J., Herzenberg L. A., Strominger J. L. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. 1986 Sep 25-Oct 1Nature. 323(6086):346–349. doi: 10.1038/323346a0. [DOI] [PubMed] [Google Scholar]
  20. Kasaian M. T., Casali P. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity. 1993;15(4):315–329. doi: 10.3109/08916939309115755. [DOI] [PubMed] [Google Scholar]
  21. Kasaian M. T., Ikematsu H., Casali P. Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies. J Immunol. 1992 May 1;148(9):2690–2702. [PMC free article] [PubMed] [Google Scholar]
  22. Kearney J. F., Bartels J., Hamilton A. M., Lehuen A., Solvason N., Vakil M. Development and function of the early B cell repertoire. Int Rev Immunol. 1992;8(2-3):247–257. doi: 10.3109/08830189209055577. [DOI] [PubMed] [Google Scholar]
  23. Kipps T. J. The CD5 B cell. Adv Immunol. 1989;47:117–185. doi: 10.1016/s0065-2776(08)60663-x. [DOI] [PubMed] [Google Scholar]
  24. Knowles D. M., 2nd, Halper J. P., Azzo W., Wang C. Y. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers. Cancer. 1983 Oct 15;52(8):1369–1377. doi: 10.1002/1097-0142(19831015)52:8<1369::aid-cncr2820520806>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  25. Knowles D. M., 2nd, Neri A., Pelicci P. G., Burke J. S., Wu A., Winberg C. D., Sheibani K., Dalla-Favera R. Immunoglobulin and T-cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: implications for lineage determination and differential diagnosis. Proc Natl Acad Sci U S A. 1986 Oct;83(20):7942–7946. doi: 10.1073/pnas.83.20.7942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Korsmeyer S. J., Hieter P. A., Ravetch J. V., Poplack D. G., Waldmann T. A., Leder P. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7096–7100. doi: 10.1073/pnas.78.11.7096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ladanyi M., Offit K., Jhanwar S. C., Filippa D. A., Chaganti R. S. MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood. 1991 Mar 1;77(5):1057–1063. [PubMed] [Google Scholar]
  28. Lo Coco F., Gaidano G., Louie D. C., Offit K., Chaganti R. S., Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood. 1993 Oct 15;82(8):2289–2295. [PubMed] [Google Scholar]
  29. Lo Coco F., Ye B. H., Lista F., Corradini P., Offit K., Knowles D. M., Chaganti R. S., Dalla-Favera R. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 1994 Apr 1;83(7):1757–1759. [PubMed] [Google Scholar]
  30. Matolcsy A., Inghirami G., Knowles D. M. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood. 1994 Mar 1;83(5):1363–1372. [PubMed] [Google Scholar]
  31. Mayer R., Logtenberg T., Strauchen J., Dimitriu-Bona A., Mayer L., Mechanic S., Chiorazzi N., Borche L., Dighiero G., Mannheimer-Lory A. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood. 1990 Apr 1;75(7):1518–1524. [PubMed] [Google Scholar]
  32. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Miyamura K., Osada H., Yamauchi T., Itoh M., Kodera Y., Suchi T., Takahashi T., Ueda R. Single clonal origin of neoplastic B-cells with different immunoglobulin light chains in a patient with Richter's syndrome. Cancer. 1990 Jul 1;66(1):140–144. doi: 10.1002/1097-0142(19900701)66:1<140::aid-cncr2820660125>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  34. Murray P. G., Janmohamed R. M., Crocker J. CD23 expression in non-Hodgkin lymphoma: immunohistochemical demonstration using the antibody BU38 on paraffin sections. J Pathol. 1991 Oct;165(2):125–128. doi: 10.1002/path.1711650207. [DOI] [PubMed] [Google Scholar]
  35. Nakamine H., Bagin R. G., Vose J. M., Bast M. A., Bierman P. J., Armitage J. O., Weisenburger D. D. Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma. Cancer. 1993 May 15;71(10):3130–3137. doi: 10.1002/1097-0142(19930515)71:10<3130::aid-cncr2820711039>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  36. Ngan B. Y., Picker L. J., Medeiros L. J., Warnke R. A. Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings. Am J Clin Pathol. 1989 May;91(5):579–583. doi: 10.1093/ajcp/91.5.579. [DOI] [PubMed] [Google Scholar]
  37. Ott M. M., Dahlheimer K., Müller-Hermelink H. K., Feller A. C. Gene rearrangement of bcl-1 and bcl-2 is confined to distinct subgroups of high-grade malignant B-cell lymphomas. J Pathol. 1993 Mar;169(3):303–307. doi: 10.1002/path.1711690305. [DOI] [PubMed] [Google Scholar]
  38. Pelicci P. G., Knowles D. M., 2nd, Magrath I., Dalla-Favera R. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1986 May;83(9):2984–2988. doi: 10.1073/pnas.83.9.2984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Picker L. J., Weiss L. M., Medeiros L. J., Wood G. S., Warnke R. A. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol. 1987 Jul;128(1):181–201. [PMC free article] [PubMed] [Google Scholar]
  40. Raghoebier S., Kramer M. H., van Krieken J. H., de Jong D., Limpens J., Kluin-Nelemans J. C., van Ommen G. J., Kluin P. M. Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma. Blood. 1991 Nov 15;78(10):2680–2685. [PubMed] [Google Scholar]
  41. Sander C. A., Yano T., Clark H. M., Harris C., Longo D. L., Jaffe E. S., Raffeld M. p53 mutation is associated with progression in follicular lymphomas. Blood. 1993 Oct 1;82(7):1994–2004. [PubMed] [Google Scholar]
  42. Siminovitch K. A., Bakhshi A., Goldman P., Korsmeyer S. J. A uniform deleting element mediates the loss of kappa genes in human B cells. Nature. 1985 Jul 18;316(6025):260–262. doi: 10.1038/316260a0. [DOI] [PubMed] [Google Scholar]
  43. Solvason N., Chen X., Shu F., Kearney J. F. The fetal omentum in mice and humans. A site enriched for precursors of CD5 B cells early in development. Ann N Y Acad Sci. 1992 May 4;651:10–20. doi: 10.1111/j.1749-6632.1992.tb24589.x. [DOI] [PubMed] [Google Scholar]
  44. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  45. Suggs S. V., Wallace R. B., Hirose T., Kawashima E. H., Itakura K. Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6613–6617. doi: 10.1073/pnas.78.11.6613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sun T., Susin M., Desner M., Pergolizzi R., Cuomo J., Koduru P. The clonal origin of two cell populations in Richter's syndrome. Hum Pathol. 1990 Jul;21(7):722–728. doi: 10.1016/0046-8177(90)90032-z. [DOI] [PubMed] [Google Scholar]
  47. Taub R. A., Hollis G. F., Hieter P. A., Korsmeyer S., Waldmann T. A., Leder P. Variable amplification of immunoglobulin lambda light-chain genes in human populations. Nature. 1983 Jul 14;304(5922):172–174. doi: 10.1038/304172a0. [DOI] [PubMed] [Google Scholar]
  48. Weiss L. M., Strickler J. G., Warnke R. A., Purtilo D. T., Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol. 1987 Oct;129(1):86–91. [PMC free article] [PubMed] [Google Scholar]
  49. Wikén M., Björck P., Axelsson B., Perlmann P. Induction of CD43 expression during activation and terminal differentiation of human B cells. Scand J Immunol. 1988 Oct;28(4):457–464. doi: 10.1111/j.1365-3083.1988.tb01476.x. [DOI] [PubMed] [Google Scholar]
  50. Williams M. E., Meeker T. C., Swerdlow S. H. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood. 1991 Jul 15;78(2):493–498. [PubMed] [Google Scholar]
  51. Yanagi Y., Yoshikai Y., Leggett K., Clark S. P., Aleksander I., Mak T. W. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature. 1984 Mar 8;308(5955):145–149. doi: 10.1038/308145a0. [DOI] [PubMed] [Google Scholar]
  52. Ye B. H., Lista F., Lo Coco F., Knowles D. M., Offit K., Chaganti R. S., Dalla-Favera R. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 1993 Oct 29;262(5134):747–750. doi: 10.1126/science.8235596. [DOI] [PubMed] [Google Scholar]
  53. Zelenetz A. D., Chen T. T., Levy R. Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med. 1991 Jan 1;173(1):197–207. doi: 10.1084/jem.173.1.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zukerberg L. R., Medeiros L. J., Ferry J. A., Harris N. L. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol. 1993 Oct;100(4):373–385. doi: 10.1093/ajcp/100.4.373. [DOI] [PubMed] [Google Scholar]
  55. van den Oord J. J., de Wolf-Peeters C., Pulford K. A., Mason D. Y., Desmet V. J. Mantle zone lymphoma. Immuno- and enzymehistochemical studies on the cell of origin. Am J Surg Pathol. 1986 Nov;10(11):780–788. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES